Driving Innovation in Ophthalmic Tissue Engineering
Discover key insights and milestones that define our success in ophthalmology research.
Impact
Experience in publishing in competitive, prestigious journals such as Nature Communications, Blood, ACS Nano, Nano Letters, and more!
Passion
Our team is dedicated to innovation with over 15 years of scientific experience.
Unity
We believe in a multifaceted approached to science and have established collaborations with ophthalmologists, dermatologists, pharmaceutical chemists, engineers and more!
Skill
We have received extensive training and formal education from accredited universities. We are up to date on the latest literature surrounding Ophthalmic challenges and are prepared to offer innovative solutions at an affordable rate
Meet Our Founder & CEO
Our founder is passionate about translating therapies from the bench to the bedside and offering patients the best possible therapies.
Career (~200 words)
Dimitri Arhontoulis is an MD/PhD physician-scientist working at the intersection of ophthalmology, biomedical engineering, and translational immunology. His research focuses on engineering biomaterials and cellular systems that interact with immune responses to improve surgical outcomes and address unmet challenges in retinal disease.
During his doctoral training in tissue engineering through a Medical Scientist Training Program (MSTP), Dimitri developed approaches to engineer functional microtissues and design cellular therapies capable of modulating host immune responses. His work explored strategies to engineer immune cells and stem cell–derived systems that could avoid or reshape the host response, improving tissue integration and therapeutic durability. This training established a foundation in biomaterials design, immune–tissue interactions, and translational biomedical engineering.
Dimitrios Arhontoulis, MD, PhD
Ophthalmology Resident
Known for his infectious enthusiasm and creativity, Dimitri is eager to make a difference in ophthalmic research.
In addition to his role as a resident physician, he is the Principal Scientist & Lead Engineer for the innovative CASEx Miami leading the NRSS project
Dimitri’s work has contributed to publications in leading journals including ACS Nano, Nano Letters, Nature Communications, and Blood through interdisciplinary collaborations spanning biomaterials engineering, nanotechnology, and immunology. His research training was supported by the prestigious Ruth L. Kirschstein NRSA F30 fellowship.
He recently matched into ophthalmology residency at Washington University School of Medicine in St. Louis, where he will begin training in 2026 and plans to investigate how tissue engineering and immune regulation can be leveraged to treat retinal disease, ocular oncology, and uveitis.